Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The aim of the Real-Life Trials in Oncology Programme is to provide competitive funding conditions to clinical researchers to develop their trials in France and Spain.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. - Tel.: 93.316.05.76.
  • Marta López: mlopez4@imim.es - Ext.: 1576
  • Mercedes Bayo: mbayo@imim.es - Ext.: 1684
    		•
    Convocatòria (URL)
    https://criscancer.org/es/convocatorias-real-life-trial-in-oncology-2022/
    Requisits
    Training
  • Applications will be admitted from specialist physicians in France or Spain, who have proven experience on developing and managing independent clinical trials.
    Nationality
  • Real-Life Trials in Oncology Programme is open to clinical researchers of any nationality working at French or Spanish hospitals.
    Clinical Trial
  • Candidates must provide a proposal of the clinical trial associated with the call for applicationsand which will be the object of funding. The clinical trial shall demonstrate a high level of methodology and scientific quality.
  • The trial must be practice-changing or practice-informing and must have a measurable impact on patient outcome and patient management, whether the primary endpoint is met or not.
    Principal Investigator (PI)
  • There will be two Principal Investigators, a Spanish PI (working at a Spanish institution) and a French PI (working at a French institution)
  • Information about their background must be provided along with the application.
  • Both investigators shall show an active role in the development of the clinical trial.
    • Dotació
    The maximum amount awarded will be €1.500.000, which will be divided among the awarded proposals and spread over three annual instalments according to the budget calendar description, which must detail the annual breakdown of the budget, not exceeding €500.000 per year summing up all the proposals awarded.
    Durada
    The trial should run for a maximum of 3 years.
    Documentació
    All applications must provide two blocks of documentation, which must be completed entirely in English.

    The Clinical Trial proposal form, available at the website, includes the following elements:
  • General information about the candidates and institutions:
    - Spanish PI: First and last name, institution, and contact details
    - French PI: First and last name, institution, and contact details

  • Information of the Clinical Trial:
    - General information of the trial: Title, code/acronym, keywords, design of the Clinical Trial...
    - Background, hypothesis, objectives, endpoints, methodology, project description, duration, and work plan.
    - Project resources and budget detailing foreseen annual costs and payment schedule by study milestones.
    - Expected impact of the proposed research.
    - Project schedule.

    Candidates should also include at the application their Curriculum Vitae, using a standardised summarised format following an abbreviated template of standard forms for public calls for applications (for example CVA). This document must be provided in English.
  • Spanish PI’s abbreviated CV (maximum 5 pages)
  • French PI’s abbreviated CV (maximum 5 pages)

    The requested documents must be submitted in PDF format (no more than 4Mb). These documents may be provided in English language. Documents must be clear and legible. In addition, each page of the original document must correspond to a page of the PDF document.

    About the Clinical Trial Proposal form: The template provided must be used, and the report must not exceed 2 pages, excluding administrative information of the proposal, general information of the trial, budget, bibliography, graphs, and figures. The format of the text should be as follows:
    ➢ Din A4.
    ➢ Calibri, Times New Roman, Arial or Helvetica.
    ➢ Font size 11 or 12.
    ➢ Single line spacing.
    ➢ Margins: 2 cm on either side.
    		•

    Arxius

    Arxiu
    RLTiO-FAQs-2022_v2.pdf
    RLTiO-proposal-clinical-trial-form-2022.docx
    RLTiO-schedule-2022.pdf
    RLTiO-FAQs-2022.pdf
    RLTiO-terms-and-conditions-2022.pdf